David Albala, MD


Algorithms for Diagnostic Testing in Prostate Cancer

June 24, 2021

Key opinion leaders in urology review factors to consider when selecting screening and risk-assessment tests for the diagnosis of prostate cancer including insurance coverage, commercial availability, and patient preference.

COVID-19: Telehealth and Compliance in Prostate Cancer

June 24, 2021

David Albala, MD and Judd W. Moul, MD consider the impact that COVID-19 has had on the clinical experience of patients with prostate cancer and share personal insights regarding telehealth and patient compliance.